Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
next day could not walk still can not; This serious case was reported by a consumer via interactive digital media and described the occurrence of unable to walk in a adult female patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. In OCT-2023, the patient received RSV vaccine. In OCT-2023, 1 day after receiving RSV vaccine, the patient experienced unable to walk (Verbatim: next day could not walk still can not) (serious criteria disability). The outcome of the unable to walk was not resolved. It was unknown if the reporter considered the unable to walk to be related to RSV vaccine. The company considered the unable to walk to be unrelated to RSV vaccine. Additional Information: GSK Receipt Date: 25-MAR-2025 This case was reported by a consumer via interactive digital media. The reporter reported that his wife got the shot in October 2023 next day could not walk still could not. The doctor said nothing could do help, be very careful of this shot.; Sender's Comments: Gait inability is an unlisted event which is considered unrelated to GSK RSV vaccine.